Weighted Average Number of Shares Outstanding, Diluted of Organogenesis Holdings Inc. from 31 Mar 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Organogenesis Holdings Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Mar 2017 to 31 Dec 2025.
  • Organogenesis Holdings Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Dec 2025 was 130,248,412, a 1.1% decline year-over-year.
  • Organogenesis Holdings Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2025 was 130,248,412, a 1.1% decline from 2024.
  • Organogenesis Holdings Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 131,673,278, a 0.81% decline from 2023.
  • Organogenesis Holdings Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 132,746,727, a 0.28% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Organogenesis Holdings Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 130,248,412 -1,424,866 -1.1% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 130,848,995 -3,077,760 -2.3% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 133,926,755 +1,353,602 +1% 01 Apr 2025 30 Jun 2025 10-Q 06 Nov 2025 2025 Q3
Q1 2025 126,295,642 -5,566,130 -4.2% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 131,673,278 -1,073,449 -0.81% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 133,926,755 +509,034 +0.38% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 132,573,153 -492,857 -0.37% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 131,861,772 +777,931 +0.59% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 132,746,727 +363,575 +0.28% 01 Oct 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 133,417,721 +1,184,767 +0.9% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024 2024 Q3
Q2 2023 133,066,010 +465,431 +0.35% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 131,083,841 +2,295,120 +1.8% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 132,383,152 -1,279,507 -0.96% 01 Oct 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
Q3 2022 132,232,954 -1,617,262 -1.2% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 132,600,579 -1,387,834 -1% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 128,788,721 -4,663,229 -3.5% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q4 2021 133,662,659 +22,301,828 +20% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 133,850,216 +25,360,448 +23% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 133,988,413 +29,273,688 +28% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q2
Q1 2021 133,451,950 +28,965,026 +28% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 111,360,831 01 Oct 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
Q3 2020 108,489,768 +16,212,910 +18% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 104,714,725 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 104,486,924 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1
Q3 2019 92,276,858 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q4 2017 64,121,501 01 Oct 2017 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 64,040,527 01 Jul 2017 30 Sep 2017 10-K 18 Mar 2019 2018 FY
Q2 2017 64,022,549 01 Apr 2017 30 Jun 2017 10-K 18 Mar 2019 2018 FY
Q1 2017 66,670,850 01 Jan 2017 31 Mar 2017 10-K 18 Mar 2019 2018 FY

Organogenesis Holdings Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 130,248,412 -1,424,866 -1.1% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 131,673,278 -1,073,449 -0.81% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 132,746,727 +363,575 +0.28% 01 Jan 2023 31 Dec 2023 10-K 26 Feb 2026 2025 FY
2022 132,383,152 -1,279,507 -0.96% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 133,662,659 +22,301,828 +20% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 111,360,831 +18,520,430 +20% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023 2022 FY
2019 92,840,401 +23,521,945 +34% 01 Jan 2019 31 Dec 2019 10-K 01 Mar 2022 2021 FY
2018 69,318,456 01 Jan 2018 31 Dec 2018 10-K 16 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.